02 February 2021
Professor John Terry, Director of the Centre for Systems Modelling and Quantitative Biomedicine, has been awarded a prestigious Established Career Fellowship.
01 February 2021
Scientists have discovered how 'weak' cells bond with their more mature cellular counterparts to boost the body's insulin production.
01 February 2021
A clinical trial has shown that digoxin has the same effect on physical wellbeing as beta-blockers when treating patients with permanent atrial fibrillation.
29 January 2021
Professor Pam Kearns, Director of the Institute of Cancer and Genomic Sciences, writes an opinion piece on how COVID-19 has replaced cancer as 'the big C'.
27 January 2021
Dr Christopher O'Shea from at the Institute of Cardiovascular Sciences has been awarded a prestigious Postdoctoral Fellowship from the Wellcome Trust.
27 January 2021
The University of Birmingham and two centres have been chosen to deliver high impact training courses as part of the Advanced Therapies Skills Training Network.
25 January 2021
Patients' chances of survival after cancer surgery is strongly linked with the standard of post-operation hospital care, a major international study suggests.
22 January 2021
The Barber Institute of Fine Arts has been awarded £40,000 from the Art Fund's Respond & Reimagine scheme for a major health and wellbeing initiative for 2021.
21 January 2021
Schools are closing again in response to surging levels of COVID-19 infection, but staging randomised trials when students eventually return could help.
19 January 2021
The fatal threat from diarrhoea and pneumonia to young children in the world's poorer countries can be reduced by using traditional performing arts to encourage mothers to provide youngsters with safe food and water.
18 January 2021
Latest study found that around a third of healthcare workers reported increased symptoms of anxiety and depression following the initial COVID-19 pandemic peak.
18 January 2021
Maternal healthcare leaders have called for lifesaving research into pharmaceuticals for use during pregnancy in response to pregnancy-related complications.